Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Angiogenesis. 2014 Feb 23;17(3):675–683. doi: 10.1007/s10456-014-9423-8

Figure 3. Quantitation of ECFC lumenal area in response to exogenous addition of rhANGPTL2 domains.

Figure 3

The average lumenal area of ECFC derived 3D vascular structures treated with recombinant human angiopoietin-like protein 2 fibrinogen-like domain (FLD), coiled-coil domain (CCD), or vehicle (control) was calculated. CCD treatment but not FLD significantly improved lumen formation in ECFCs. RQ = relative quantity; n = 3. Since there were no technical replicates in this experiment, the standard error of the mean was included with the average of each biological replicate to illustrate the size range of the vascular structures measured; there were 324 structures measured on average per well. Statistical analysis: Kruskal-Wallis test with Dunn post-test.